Malaria Epidemiology: Specific Vulnerable Group in the Population

Main Article Content

Forman Erwin Siagian


Malaria is a potentially fatal vector borne disease caused by the blood protozoan, Plasmodium spp. The number of species of Plasmodium spp continues to grow; even nowadays there is zoonosis based species that infect human. Morbidity and mortality still difficult to control, with sub Sahara Africa and south East Asia still the epicentrum of persistent transmission. Human behavior is one of the predisposing factors and actually there is a specific vulnerable group in the Population. It consists of pregnant women, children (especially under five years old) and travellers. They are at risk and very vulnerable with separated specific reason. There is no single action can be successfully applicable for them, because preventive approach must be conducted based on each group specific characteristics. In order to prevent the spread of transmission, active surveillance is one of the tools used. Preventive action conducted tailor made based on each specific group with adjustment when applicable in different region. Lesson learned from the effort to tackle malaria so far and to try to adjust it into specific vulnerable population and future direction being made in order to eliminate malaria and to create world free malaria.

Blood protozoa, children, pregnant women, travellers, active surveillance, vector.

Article Details

How to Cite
Siagian, F. E. (2020). Malaria Epidemiology: Specific Vulnerable Group in the Population. International Journal of Research and Reports in Hematology, 3(2), 41-52. Retrieved from
Systematic Review Article


Molyneux D. Malaria eradication. The Lancet, 2020;395:10233, e71.

Siagian F, Ronny, Sirra A, Susiantoro U, Siregar M. Malaria related myalgia-arthralgia: an imported case report treated with antimalarial drug. Int J Basic Clin Pharmacol. 2020;9(10):1603-6
DOI: 10.18203/2319-2003.ijbcp20203964

Garrido-Cardenas JA, Cebrián-Carmona J, González-Cerón L, Manzano-Agugliaro F, Mesa-Valle C. Analysis of Global Research on Malaria and Plasmodium vivax. Int J Environ Res Public Health. 2019;16(11):1928.
DOI: 10.3390/ijerph16111928. PMID: 31159165; PMCID: PMC6603864.

World Health Organization; 2019. World malaria report 2019.
Available: License: CC BY-NC-SA 3.0 IGO. 185 p. ISBN. 9789241565721.

Alegana VA, Okiro EA, Snow RW. Routine data for malaria morbidity estimation in Africa: challenges and prospects. BMC Med. 2020;18:121.

Lourenço C, Tatem AJ, Atkinson PM, Cohen JM, Pindolia D, Bhavnani D, et al. Strengthening surveillance systems for malaria elimination: a global landscaping of system performance, 2015-2017. Malar J. 2019;18(1):315.
DOI: 10.1186/s12936-019-2960-2. PMID: 31533740; PMCID: PMC6751607.

Ryan SJ, Lippi CA, Zermoglio F. Shifting transmission risk for malaria in Africa with climate change: a framework for planning and intervention. Malar J. 2019;19:170.

Takem EN, D'Alessandro U. Malaria in Pregnancy. Mediterranean Journal of Hematology and Infectious Diseases. 2013;5(1):e2013010.
DOI: 10.4084/MJHID.2013.010

Degarege A, Fennie K, Degarege D, Chennupati S, Madhivanan P. Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis. PLOS ONE. 2019;14(1):e0211205.

Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, et al. The Impact of Placental Malaria on Gestational Age and Birth Weight, The Journal of Infectious Diseases. 2000;181(5):1740–5.

Steketee RW. Weighing in on malaria-attributable low birthweight in Africa. The Lancet Global Health. 2014;2(8):e434-e435

García MD, Solana CF, Ugarriza AV, Moreno CB, Palazón EM, Botaya RM. Imported malaria cases: the connection with the European ex-colonies. . Malar J. 2019;18:397

Angelo, K.M., Libman, M., Caumes, E. Malaria after international travel: a GeoSentinel analysis, 2003–2016. Malar J. 2017;16:293.

Tatem AJ, Jia P, Ordanovich D, Falkner M, Huang Z, Howes R, Hay SI, Gething PW, Smith DL. The geography of imported malaria to non-endemic countries: A meta-analysis of nationally reported statistics. Lancet Infect Dis. 2017;17(1):98-107.
DOI: 10.1016/S1473-3099(16)30326-7. Epub 2016 Oct 21. PMID: 27777030; PMCID: PMC5392593.

Cohee LM, Laufer MK. Malaria in Children. Pediatr Clin North Am. 2017;64(4):851-866.
DOI: 10.1016/j.pcl.2017.03.004. PMID: 28734514; PMCID: PMC5733786.

Franke-Fayard B, Fonager J, Braks A, Khan SM, Janse CJ. Sequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria?. PLOS Pathogens. 2010;6(9):e1001032.

Ssentongo P, Ba DM, Ssentongo AE, Ericson JE, Wang M, Liao D, Chinchilli VM. Associations of malaria, HIV, and coinfection, with anemia in pregnancy in sub-Saharan Africa: a population-based cross-sectional study. BMC Pregnancy Childbirth. 2020;20(1):379.
DOI: 10.1186/s12884-020-03064-x. PMID: 32600355; PMCID: PMC7324981.

Patriani, D., Arguni, E., Kenangalem, E. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infect Dis. 2019;19:922.

Behrens R, Carroll B, Hellgren U, Visser L, Siikamäki H, Vestergaard L, et al. The incidence of malaria in travellers to South-East Asia: Is local malaria transmission a useful risk indicator?. Malaria journal. 2010;9:266.
DOI: 10.1186/1475-2875-9-266

Franco-Paredes C, Santos-Preciado JI. Problem pathogens: prevention of malaria in travellers. Lancet Infect Dis 2006; 6: 139–49

Lalloo DG, Hill DR. Preventing malaria in travellers. BMJ. 2008 Jun 14;336(7657):1362-6. doi: 10.1136/bmj.a153. PMID: 18556317; PMCID: PMC2427103.

Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016 Mar-Apr;27(2):89-94. doi: 10.5830/CVJA-2016-021. PMID: 27213856; PMCID: PMC4928162.

Accrombessi M, Fievet N, Yovo E, Cottrell G, Agbota G, Massougbodji A, et al. Prevalence and Associated Risk Factors of Malaria in the First Trimester of Pregnancy: A Preconceptional Cohort Study in Benin, The Journal of Infectious Diseases, 2018; 217(8):1309–17,

Adam I, Ismail MH, Nasr AM, Prins MH, Smits LJM. Low birth weight, preterm birth and short interpregnancy interval in Sudan, The Journal of Maternal-Fetal & Neonatal Medicine, 2009;22(11):1068-71.
DOI: 10.3109/14767050903009222

Dhiman S, Yadav K, Goswami D, Das N, Baruah I, Singh L. Epidemiology and Risk Analysis of Malaria among Pregnant Women. Iran J Public Health. 2012;41(1):1-8. Epub 2012 Jan 31. PMID: 23113116; PMCID: PMC3481657.

Osaro E, Abdullahi A, Tosan E, Charles AT. Risk factors associated with malaria infection among pregnant women of African Descent in Specialist Hospital Sokoto, Nigeria. Obstet Gynecol Int J. 2019;10(4):274‒80.
DOI: 10.15406/ogij.2019.10.00454

Piñeros JG, Tobon-Castaño A, Alvarez G, Portilla C, Blair S. Maternal clinical findings in malaria in pregnancy in a region of northwestern Colombia. Am J Trop Med Hyg. 2013;89(3):520-6.
DOI: 10.4269/ajtmh.12-0205. Epub 2013 Jul 29. PMID: 23897991; PMCID: PMC3771293.

Saba N, Sultana A, Mahsud I. Outcome and complications of malaria in pregnancy. Gomal Journal of Medical Sciences, 2008;6(2):98-101

Briand V, Badaut C, Cot M. Placental malaria, maternal HIV infection and infant morbidity. Annals of Tropical Paediatrics International Child Health, 2009;29(2):71-83.
DOI: 10.1179/146532809X440699

McLean AR, Ataide R, Simpson JA, Beeson JG, Fowkes FJ. Malaria and immunity during pregnancy and postpartum: a tale of two species. Parasitology. 2015;142(8):999-1015.
DOI: 10.1017/S0031182015000074

Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet (London, England). 2004;363(9424):1860-1867.
DOI: 10.1016/s0140-6736(04)16354-x.

Rochford, R, Kazura, J. Introduction: Immunity to malaria. Immunol Rev. 2020;293:5–7.

Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13-36, Table of Contents.
DOI: 10.1128/CMR.00025-08. PMID: 19136431; PMCID: PMC2620631.

Rogerson SJ, Mwapasa V, Meshnick SR. Malaria in Pregnancy: Linking Immunity and Pathogenesis to Prevention. In: Breman JG, Alilio MS, White NJ, editors. Defining and Defeating the Intolerable Burden of Malaria III: Progress and Perspectives: Supplement of American Journal of Tropical Medicine and Hygiene. Northbrook (IL): American Society of Tropical Medicine and Hygiene; 2007;77(6).

Kwenti TE. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies. Res Rep Trop Med. 2018;9:123-136.

Bediako Y, Adams R, Reid AJ. Repeated clinical malaria episodes are associated with modification of the immune system in children. BMC Med, 2019;17:60.

Lugaajju, A, Reddy, SB, Wahlgren M. Development of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area. Malar J. 2017;16:37.

Anna-Karin PE, Carole H. Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination. Frontiers in Immunology, 2019;10:1787.

Ly A, Hansen DS. Development of B Cell Memory in Malaria. Front Immunol. 2019;10:559.
DOI: 10.3389/fimmu.2019.00559. PMID: 31001244; PMCID: PMC6454213.

Bucşan AN, Williamson KC. Setting the stage: The initial immune response to blood-stage parasites. Virulence. 2020;11(1):88-103.

Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev. 2008;21(3):466-72.
DOI: 10.1128/CMR.00059-07.
PMID: 18625682;
PMCID: PMC2493087.

Heywood AE, Zwar N. Improving access and provision of pre-travel healthcare for travellers visiting friends and relatives: a review of the evidence, Journal of Travel Medicine, 2018;25(1):tay010.

World health organization. A framework for malaria elimination. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.

MEASURE Evaluation. Facilitating Surveillance, Monitoring, and Evaluation in Malaria-Endemic Countries: A Compendium for National Malaria Programs. Chapel Hill, NC, USA: MEASURE Evaluation, University of North Carolina; 2020.

Wirth DF, Casamitjana N, Tanner M. Global action for training in malaria elimination. Malar J. 2018;17:51.

The Global Fund. Strategy Development: Landscape Analysis – Malaria. Preliminary version; 2020.

Shiff C. Integrated approach to malaria control. Clin Microbiol Rev. 2002;15(2):278-93.
DOI: 10.1128/cmr.15.2.278-293.2002. PMID: 11932233; PMCID: PMC118067.

Tizifa TA, Kabaghe AN, McCann RS, van den Berg H, Van Vugt M, Phiri KS. Prevention Efforts for Malaria. Curr Trop Med Rep. 2018;5(1):41-50.
DOI: 10.1007/s40475-018-0133-y. Epub 2018 Feb 8. PMID: 29629252; PMCID: PMC5879044.

Inungu JN, Ankiba N, Minelli M, Mumford V, Bolekela D, Mukoso B, Onema W, Kouton E, Raji D. Use of Insecticide-Treated Mosquito Net among Pregnant Women and Guardians of Children under Five in the Democratic Republic of the Congo. Malar Res Treat. 2017;2017:5923696.
DOI: 10.1155/2017/5923696. Epub 2017 Nov 6. PMID: 29234551; PMCID: PMC5694996.

Boubaker R, Fossati AH, Meige M, Mialet C, Buffat CN, Rochat J, et al. Malaria prevention strategies and recommendations, from chemoprophylaxis to stand-by emergency treatment: a 10-year prospective study in a Swiss Travel Clinic, Journal of Travel Medicine, 2017;24(5):tax043.

Coldiron ME, Von Seidlein L, Grais RF. Seasonal malaria chemoprevention: successes and missed opportunities. Malar J, 2017;16:481.

Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database of Systematic Reviews. 2006;4. Art. No.: CD000169.
DOI: 10.1002/14651858.CD000169.pub2.

Mlugu EM, Minzi O, Asghar M, Färnert A, Kamuhabwa AAR, Aklillu E. Effectiveness of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria and adverse birth outcomes in pregnant women. Pathogens. 2020;9(3):207.
DOI: 10.3390/pathogens9030207. PMID: 32168945; PMCID: PMC7157612.

Anto F, Agongo IH, Asoala V, Awini E, Oduro AR. Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana, Journal of Tropical Medicine; 2019, Article ID 6712685, 10 pages, 2019.

Hansen KS, Ndyomugyenyi R, Magnussen P, Clarke SE. Cost-effectiveness analysis of three health interventions to prevent malaria in pregnancy in an area of low transmission in Uganda. Int Health. 2012;4(1):38-46.
DOI: 10.1016/j.inhe.2011.10.001. PMID: 24030879; PMCID: PMC4197998.

Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine/pyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf. 2007;30(6):481- 501.
DOI: 10.2165/00002018-200730060-00003. PMID: 17536875.

Shah SN, Smith EE, Obonyo CO, Kain KC, Bloland PB, Slutsker L, et al. HIV Immunosuppression and Antimalarial Efficacy: Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Malaria in HIV-Infected Adults in Siaya, Kenya, The Journal of Infectious Diseases, 2006; 194(11):1519–28

Zhao L, Pi L, Qin Y, Lu Y, Zeng W, Xiang Z, et al. Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa. International Journal for Parasitology: Drugs and Drug Resistance. 2020;12:1-6.